Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WRB-SH3BGR readthrough is a naturally occurring chimeric transcript resulting from the readthrough transcription between WRB (encoding a mitochondrial or ER membrane protein) and SH3BGR (encoding an SH3 domain-binding glutamate-rich protein) on chromosome 21. This readthrough event generates a transcript that may encode a fusion protein sharing components of the parental proteins. There is limited information available regarding the biological function, therapeutic targeting, or disease associations of this fusion transcript, although it is annotated in genomic databases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WRB-SH3BGR readthrough transcript (WRB-SH3BGR).